RxDoctor Payments Data

Andrea Garey, NP

Family · Post Falls, IDNPI 1952063802

Payments from drug & device makers

$2,247in general payments, 2019–2025

Across 132 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$385
  • Exact Sciences$280
  • GSK$271
  • Amgen$198
  • AstraZeneca$171
  • Novo Nordisk$143
  • plus $798 from 17 others

What the payments were for

  • Food & beverage$2,247100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,247 in reported general payments places this provider in the 85th percentile of 809 family providers in Idaho.

See all family providers in Idaho

Medicare billing

Part B allowed, 2024
$997
Medicare patients
30
Services billed
51

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin39$55,637
OzempicSemaglutide34$53,797
MounjaroTirzepatide24$43,816
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$34,670
EliquisApixaban26$28,028
Nurtec OdtRimegepant Sulfate11$24,393
TradjentaLinagliptin12$6,036
FarxigaDapagliflozin Propanediol12$5,241
Atorvastatin Calcium318$3,829
Albuterol Sulfate HfaAlbuterol Sulfate106$2,709
Esomeprazole Magnesium23$2,413
Gabapentin111$2,184
Omeprazole151$1,828
Venlafaxine Hcl ErVenlafaxine Hcl37$1,763
Potassium Citrate ErPotassium Citrate11$1,494

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$70$61,67351 claims
Novo NordiskOzempic$143$53,79734 claims
PfizerEliquis, Nurtec Odt$59$52,42037 claims
Lilly USA, LLCMounjaro$123$43,81624 claims
GSKTrelegy Ellipta$271$34,67035 claims
AstraZenecaFarxiga$171$5,24112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 809 family providers in Idaho.

Other family in Post Falls

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →